Skip to main content

previous disabled Page of 4
and
  1. Article

    Open Access

    Imagine beyond: recent breakthroughs and next challenges in mammary gland biology and breast cancer research

    On 8 December 2022 the organizing committee of the European Network for Breast Development and Cancer labs (ENBDC) held its fifth annual Think Tank meeting in Amsterdam, the Netherlands. Here, we embraced the ...

    Renée van Amerongen, Mohamed Bentires-Alj in Journal of Mammary Gland Biology and Neopl… (2023)

  2. Article

    Open Access

    RAC1B function is essential for breast cancer stem cell maintenance and chemoresistance of breast tumor cells

    Breast cancer stem cells (BCSC) are presumed to be responsible for treatment resistance, tumor recurrence and metastasis of breast tumors. However, development of BCSC-targeting therapies has been held back by...

    Fuhui Chen, Sevim B. Gurler, David Novo, Cigdem Selli, Denis G. Alferez in Oncogene (2023)

  3. Article

    Open Access

    Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer

    Marta Palafox, Laia Monserrat, Meritxell Bellet in Nature Communications (2022)

  4. Article

    Open Access

    High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer

    CDK4/6 inhibitors combined with endocrine therapy have demonstrated higher antitumor activity than endocrine therapy alone for the treatment of advanced estrogen receptor-positive breast cancer. Some of these ...

    Marta Palafox, Laia Monserrat, Meritxell Bellet in Nature Communications (2022)

  5. Article

    Open Access

    Correction: Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women

    Thomas E. Bartlett, Iona Evans, Allison Jones, James E. Barrett in Genome Medicine (2022)

  6. Article

    Open Access

    Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women

    Breast cancer is a leading cause of death in premenopausal women. Progesterone drives expansion of luminal progenitor cells, leading to the development of poor-prognostic breast cancers. However, it is not kn...

    Thomas E. Bartlett, Iona Evans, Allison Jones, James E. Barrett in Genome Medicine (2022)

  7. Article

    Open Access

    FAK inhibition alone or in combination with adjuvant therapies reduces cancer stem cell activity

    Cancer stem-like cells (CSC) contribute to therapy resistance and recurrence. Focal adhesion kinase (FAK) has a role in CSC regulation. We determined the effect of FAK inhibition on breast CSC activity alone a...

    Simon Timbrell, Hosam Aglan, Angela Cramer, Phil Foden, David Weaver in npj Breast Cancer (2021)

  8. Article

    Open Access

    Time-resolved single-cell analysis of Brca1 associated mammary tumourigenesis reveals aberrant differentiation of luminal progenitors

    It is unclear how genetic aberrations impact the state of nascent tumour cells and their microenvironment. BRCA1 driven triple negative breast cancer (TNBC) has been shown to arise from luminal progenitors yet li...

    Karsten Bach, Sara Pensa, Marija Zarocsinceva, Katarzyna Kania in Nature Communications (2021)

  9. Article

    Open Access

    Targeting STAT3 signaling using stabilised sulforaphane (SFX-01) inhibits endocrine resistant stem-like cells in ER-positive breast cancer

    Estrogen receptor (ER) positive breast cancer is frequently sensitive to endocrine therapy. Multiple mechanisms of endocrine therapy resistance have been identified, including cancer stem-like cell (CSC) activ...

    Bruno M. Simões, Angélica Santiago-Gómez, Chiara Chiodo, Tiago Moreira in Oncogene (2020)

  10. Article

    Open Access

    Development of clinically relevant in vivo metastasis models using human bone discs and breast cancer patient-derived xenografts

    Late-stage breast cancer preferentially metastasises to bone; despite advances in targeted therapies, this condition remains incurable. The lack of clinically relevant models for studying breast cancer metasta...

    Diane Lefley, Faith Howard, Fawaz Arshad, Steven Bradbury in Breast Cancer Research (2019)

  11. Article

    Open Access

    Microenvironmental IL1β promotes breast cancer metastatic colonisation in the bone via activation of Wnt signalling

    Dissemination of tumour cells to the bone marrow is an early event in breast cancer, however cells may lie dormant for many years before bone metastases develop. Treatment for bone metastases is not curative, ...

    Rachel Eyre, Denis G. Alférez, Angélica Santiago-Gómez in Nature Communications (2019)

  12. Article

    Open Access

    The Milk Protein Alpha-Casein Suppresses Triple Negative Breast Cancer Stem Cell Activity Via STAT and HIF-1alpha Signalling Pathways in Breast Cancer Cells and Fibroblasts

    Triple negative breast cancer (TNBC) is the most lethal breast cancer subtype. Extended periods of lactation protect against breast cancer development, but the mechanisms underlying this protection are unknown...

    Kirsten E. L. Garner, Nathan J. Hull in Journal of Mammary Gland Biology and Neopl… (2019)

  13. Article

    Open Access

    FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4

    Optimising breast cancer treatment remains a challenge. Resistance to therapy is a major problem in both ER- and ER+ breast cancer. Tumour recurrence after chemotherapy and/or targeted therapy leads to more ag...

    Lana McClements, Stephanie Annett, Anita Yakkundi, Martin O’Rourke in BMC Cancer (2019)

  14. Article

    Open Access

    The Role of Steroid Hormones in Breast and Effects on Cancer Stem Cells

    This review will discuss how the steroid hormones, estrogen and progesterone, as well as treatments that target steroid receptors, can regulate cancer stem cell (CSC) activity. The CSC theory proposes a hierar...

    Denis G. Alferez, Bruno M. Simões, Sacha J. Howell in Current Stem Cell Reports (2018)

  15. Article

    Open Access

    GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment

    The G protein estrogen receptor GPER/GPR30 mediates estrogen action in breast cancer cells as well as in breast cancer-associated fibroblasts (CAFs), which are key components of microenvironment driving tumor ...

    Ernestina M. De Francesco, Andrew H. Sims, Marcello Maggiolini in Breast Cancer Research (2017)

  16. Article

    Erratum: Interrogating open issues in cancer medicine with patient-derived xenografts

    Nature Reviews Cancer 17, 254–268 (2017) In the online html version of this article, Joan Seoane's affiliations were not correct. He is also a member of the EurOPDX Consortium and is at the Vall d'Hebron Insti...

    Annette T. Byrne, Denis G. Alférez, Frédéric Amant in Nature Reviews Cancer (2017)

  17. No Access

    Article

    Interrogating open issues in cancer precision medicine with patient-derived xenografts

    This Opinion article discusses progress and challenges in using patient-derived xenograft (PDX) models in cancer precision medicine. It is primarily co-authored by members of the EurOPDX Consortium and as such...

    Annette T. Byrne, Denis G. Alférez, Frédéric Amant in Nature Reviews Cancer (2017)

  18. Article

    Erratum to: Patient-Derived Mammosphere and Xenograft Tumour Initiation Correlates with Progression to Metastasis

    Rachel Eyre, Denis G. Alférez, Kath Spence in Journal of Mammary Gland Biology and Neopl… (2016)

  19. No Access

    Article

    Patient-derived xenograft (PDX) models in basic and translational breast cancer research

    Patient-derived xenograft (PDX) models of a growing spectrum of cancers are rapidly supplanting long-established traditional cell lines as preferred models for conducting basic and translational preclinical re...

    Lacey E. Dobrolecki, Susie D. Airhart, Denis G. Alferez in Cancer and Metastasis Reviews (2016)

  20. Article

    Open Access

    Patient-derived Mammosphere and Xenograft Tumour Initiation Correlates with Progression to Metastasis

    Breast cancer specific mortality results from tumour cell dissemination and metastatic colonisation. Identification of the cells and processes responsible for metastasis will enable better prevention and contr...

    Rachel Eyre, Denis G. Alférez, Kath Spence in Journal of Mammary Gland Biology and Neopl… (2016)

previous disabled Page of 4